NCT05879926 2026-03-03
OFSET
NRG Oncology
Phase 3 Recruiting
Clinical Trials
7 trialsNCT07423611 2026-02-20
RACE
Fudan University
Phase 2 Not yet recruiting
NCT04567420 2025-10-16
DARE
Criterium, Inc.
Phase 2 Recruiting
NCT06914440 2025-07-15
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Xijing Hospital
Phase 2 Recruiting
NCT02401685 2025-07-10
POSNOC
University Hospitals of Derby and Burton NHS Foundation Trust
Phase NA Active not recruiting
NCT06996093 2025-05-30
Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor
Fudan University
Phase 3 Not yet recruiting
NCT06476119 2025-04-23
OPTImaL
The Netherlands Cancer Institute
Recruiting